Uy Ear analyst MIZUHO

Currently out of the existing stock ratings of Uy Ear, 39 are a HOLD (25%), 116 are a BUY (74.36%), 1 are a SELL (0.64%).

Uy Ear

Work Performance Price Targets & Ratings Chart

Analyst Uy Ear, currently employed at MIZUHO, has had 34.66% of price targets met with an average potential upside of 30.85%, reached in 150 days on average.

Uy Ear has documented 294 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ALKS, at 02-Jul-2026.

Wall Street Analyst Uy Ear

Analyst best performing recommendations are on QURE.
The best stock recommendation documented was for ARQT on 12/8/2023. The price target of $4 was fulfilled within 27 days with a profit of $1.84 (85.19%), with a performance score of 31.55.

Average potential price target upside

ARQT AVRO NBIX Neurocrine Biosciences ACAD ALKS EOLS OCGN SELB SRPT RVNC QURE SAGE Sage Therapeutic RLMD INAB In8bio RNAC TECX CABA

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 07-Aug-2025

$40

$11.74 (41.54%)

$35

15 days ago
(05-Nov-2026)

2/4 (50%)

$5.95 (17.47%)

55

Buy Since 25-Feb-2020

$44

$15.74 (55.70%)

$38

1 months 1 days ago
(19-Oct-2026)

1/4 (25%)

$12.11 (37.97%)

27

Buy Since 07-Sep-2022

$40

$11.74 (41.54%)

$36

3 months 14 days ago
(06-Aug-2026)

19/25 (76%)

$13.57 (51.34%)

451

Buy Since 03-Jul-2025

$34

$5.74 (20.31%)

$32

6 months 13 days ago
(07-May-2026)

4/4 (100%)

$13.34 (64.57%)

171

Buy Since 23-Feb-2024

$35

$6.74 (23.85%)

$37

8 months 18 days ago
(02-Mar-2026)

12/39 (30.77%)

$10.24 (41.36%)

270

Show more analysts

Please expand the browser size to see the chart

Which stock is Uy Ear most bullish on?

Potential upside of $44.19 has been obtained for QURE

Which stock is Uy Ear most reserved on?

Potential downside of $17.97 has been obtained for ALKS

What Year was the first public recommendation made by Uy Ear?

On 2019
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?